Infinity Pharmaceuticals, Inc.

NasdaqGS:INFI Stock Report

Mkt Cap: US$58.1m

Infinity Pharmaceuticals Financial Health

How is Infinity Pharmaceuticals's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: INFI has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: INFI has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: INFI is debt free.

Reducing Debt: INFI's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: INFI has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: INFI has sufficient cash runway for 1 years if free cash flow continues to grow at historical rates of 15.9% each year.


Discover healthy companies